About this trial
Patient Profile
Patients with completely resected stage IIIa/b/c/d or stage IV melanoma
Where’s this trial being run?
Cork University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | BMS CA209-8FC |
|---|---|
| Number: | CTRIAL-IE 19-13 |
| Full Title: | A Randomized, Double-Blind, Parallel, Phase 1 Study to Compare the Pharmacokinetics of BMSCHO1-Nivolumab Process D to Nivolumab Process C after Complete Resection of Stage IIIa/b/c/d or Stage IV Melanoma |
| Principal Investigator: | Derek Power |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | BMS |
| Recruitment Started: |
Global: Ireland: 10 |
| Global Recruitment Target: | 254 |
|---|---|
| Ireland Recruitment Target: |